reports
- Clarence Chu
Yunkang Group IPO
Yunkang Group is looking to raise US$139m in its Hong Kong IPO. Yunkang Group is a medical operation service provider in China and as per Frost & Sullivan (F&S), had a market share of 3.7% in China’s medical operation service market as per 2020 revenue. With its six independent clinic laboratories (ICL) and on-site diagnostic centers in medical institutions, it provides diagnostic testing services where diagnostic services fees are charged on the type and quantity of tests provided. Yunkang s...
- Clarence Chu
Yunkang Group Pre-IPO
Yunkang Group is looking to raise about US$200m in its upcoming Hong Kong IPO. Yunkang Group is a medical operation service provider in China and as per Frost & Sullivan (F&S), had a market share of 3.7% in China’s medical operation service market as per 2020 revenue. With its six independent clinic laboratories (ICL) and on-site diagnostic centers in medical institutions, it provides diagnostic testing services where diagnostic services fees are charged on the type and quantity of tests provi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.